We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
-4.7%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$310M
AUM Growth
-$45M
(-13%)
Cap. Flow
+$408K
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
99.09%
Holding
13
New
2
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
MacroGenics
MGNX
|
+$46.6M |
| 2 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$259K |
Top Sells
| 1 |
Pacira BioSciences
PCRX
|
+$38.1M |
| 2 |
ZLCS
ZALICUS INC COM NEW
ZLCS
|
+$6.68M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$1.68M |
Sector Composition
| 1 | Healthcare | 49.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PETX
1
DELISTED
Aratana Therapeutics, Inc.
PETX
| $83.1M | 26.84% |
4,351,048
| – | – |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $62.9M | 20.3% |
2,441,344
| – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $59.9M | 19.35% |
2,880,485
| – | – |
|
|
4
MacroGenics
MGNX
$262M
| $48.9M | 15.78% |
+1,780,955
| New | +$46.6M |
|
5
Altimmune
ALT
$554M
| $11.8M | 3.81% |
21,159
| – | – |
|
6
Verastem
VSTM
$507M
| $11.8M | 3.8% |
86,110
| – | – |
|
|
KBIO
7
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $11.6M | 3.76% |
329,116
| – | – |
|
|
HSTO
8
DELISTED
Histogen Inc. Common Stock
HSTO
| $7.69M | 2.48% |
5,960
| – | – |
|
|
9
Pacira BioSciences
PCRX
$1.01B
| $5.75M | 1.86% |
100,000
-724,255
| -88% | -$38.1M |
|
|
ETRM
10
DELISTED
EnteroMedics Inc.
ETRM
| $3.41M | 1.1% |
1,590
| – | – |
|
|
AVEO
11
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.51M | 0.81% |
137,212
-83,684
| -38% | -$1.68M |
|
|
SGMO
12
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $312K | 0.1% |
+22,487
| New | +$259K |
|
|
ZLCS
13
DELISTED
ZALICUS INC COM NEW
ZLCS
| – | – |
-927,830
| Closed | -$6.68M |
|
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM